Cargando…

Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association Study

OBJECTIVE: Natural killers (NK) cell function is mainly controlled by the expression of killer immunoglobulin-like receptors (KIRs) and their ligation with the corresponding ligands. The objective of this study was to investigate the putative association of KIRs, HLA class I ligands, and KIR/ligand...

Descripción completa

Detalles Bibliográficos
Autores principales:	Varbanova, Viktoria Plamenova, Mihailova, Snejina, Naumova, Elissaveta, Mihaylova, Anastasiya Petrova
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863033/ https://www.ncbi.nlm.nih.gov/pubmed/31337191 http://dx.doi.org/10.4274/tjh.galenos.2019.2019.0079

Ejemplares similares

Combined flow cytometry natural killer immunophenotyping and KIR/HLA-C genotyping reveal remarkable differences in acute myeloid leukemia patients, but suggest an overall impairment of the natural killer response
por: Cianga, Vlad Andrei, et al.
Publicado: (2023)

Killer Immunoglobulin-like Receptor (KIR) and HLA Genotypes Affect the Outcome of Allogeneic Kidney Transplantation
por: Nowak, Izabela, et al.
Publicado: (2012)

HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute viral encephalitis
por: Tuttolomondo, Antonino, et al.
Publicado: (2018)

HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute ischemic stroke
por: Tuttolomondo, Antonino, et al.
Publicado: (2019)

Killer cell immunoglobulin-like receptor (KIR) genes and their HLA ligands in a Brazilian population
por: Cardozo, Daniela Maira, et al.
Publicado: (2023)

The role of KIR genes and ligands in leukemia surveillance
por: Babor, Florian, et al.
Publicado: (2013)

Distribution of killer cell immunoglobulin-like receptors (KIR) and their HLA-C ligands in two Iranian populations
por: Hiby, Susan E., et al.
Publicado: (2009)

Killer cell immunoglobulin-like receptor (KIR) genes and their HLA-C ligands in a Ugandan population
por: Nakimuli, Annettee, et al.
Publicado: (2013)

Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function
por: Yawata, Makoto, et al.
Publicado: (2006)

Erratum to: Distribution of killer cell immunoglobulin-like receptors(KIR) and their HLA-C ligands in two Iranian populations
por: Hiby, Susan E., et al.
Publicado: (2010)

Killer-Cell Immunoglobulin-Like Receptors (KIR) in HIV-Exposed Infants in Cameroon
por: Luc-Aimé, Kagoué Simeni, et al.
Publicado: (2021)

NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their iKIR Negative Counterparts
por: Isitman, Gamze, et al.
Publicado: (2016)

KIR and HLA Genotypes Implicated in Reduced Killer Lymphocytes Immunity Are Associated with Vogt-Koyanagi-Harada Disease
por: Levinson, Ralph D., et al.
Publicado: (2016)

Genotypic diversity of the Killer Cell Immunoglobulin-like Receptors (KIR) and their HLA class I Ligands in a Saudi population
por: Omar, Suliman Y. Al, et al.
Publicado: (2016)

Diversity of Killer Cell Immunoglobulin-Like Receptor (KIR) Genotypes and KIR2DL2/3 Variants in HCV Treatment Outcome
por: Vidal-Castiñeira, Jose Ramón, et al.
Publicado: (2014)

Ligand specificity of Killer cell Immunoglobulin-like Receptors: a brief history of KIR
por: van Bergen, Jeroen, et al.
Publicado: (2012)

Killer cell immunoglobulin-like receptors (KIR) and human leukocyte antigen-C (HLA-C) allorecognition patterns in women with endometriosis
por: Chou, Ya-Ching, et al.
Publicado: (2020)

Differential natural killer cell–mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes
por: Alter, Galit, et al.
Publicado: (2007)

Killer Immunoglobulin-Like Receptor 2DS2 (KIR2DS2), KIR2DL2-HLA-C1, and KIR2DL3 as Genetic Markers for Stratifying the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients
por: Deborska-Materkowska, Dominika, et al.
Publicado: (2019)

Unusual T-Lymphoblastic Blast Phase of Chronic Myelogenous Leukemia
por: Xu, Jie, et al.
Publicado: (2014)

Frequency of Killer Cell Immunoglobulin-like Receptors (KIRs) in Korean Patients with Chronic HCV Infection
por: Sung, Pil Soo, et al.
Publicado: (2011)

Killer cell immunoglobulin-like receptor (KIR) gene content variation in the HGDP-CEPH populations
por: Hollenbach, Jill A., et al.
Publicado: (2012)

Effects of the killer immunoglobulin–like receptor (KIR) polymorphisms on HIV acquisition: A meta-analysis
por: Chaisri, Suwit, et al.
Publicado: (2019)

Allele imputation for the killer cell immunoglobulin-like receptor KIR3DL1/S1
por: Harrison, Genelle F., et al.
Publicado: (2022)

The Roles of Uterine Natural Killer (NK) Cells and KIR/HLA-C Combination in the Development of Preeclampsia: A Systematic Review
por: Yang, Xiuhua, et al.
Publicado: (2020)

In vitro education of human natural killer cells by KIR3DL1
por: Pugh, Jason, et al.
Publicado: (2019)

KIR/HLA Interactions and Pathogen Immunity
por: Jamil, Khaleel M., et al.
Publicado: (2011)

KIR genes and adult T-cell leukemia/lymphoma in patients infected with HTLV-1
por: Melo, Omar, et al.
Publicado: (2015)

The killer immunoglobulin-like receptor KIR3DL1 combination with HLA-Bw4 is protective against multiple sclerosis in African Americans
por: Hollenbach, Jill A., et al.
Publicado: (2016)

KIR/HLA genotype combinations are determinants of Natural Killer (NK) cell mediated antibody-dependent cellular cytotoxicity (ADCC) potency
por: Parsons, MS, et al.
Publicado: (2012)

First Report of a Patient With Natural Killer-Lymphoblastic Leukemia/Lymphoma in Korea
por: Lee, Jiwon, et al.
Publicado: (2019)

Killer Cell Immunoglobulin-Like Receptor (KIR) Genotype Distribution in Familial Mediterranean Fever (FMF) Patients
por: Erken, Ertugrul, et al.
Publicado: (2015)

Focal lymphoblastic transformation of chronic myelogenous leukemia develops into erythroid leukemia: A case report
por: Wang, Wei, et al.
Publicado: (2023)

Influence of Interleukin IL-2 and IL-12 + IL-18 on Surface Expression of Immunoglobulin-Like Receptors KIR2DL1, KIR2DL2, and KIR3DL2 in Natural Killer Cells
por: Chrul, Slawomir, et al.
Publicado: (2006)

Association of iKIR-mismatch model and donor aKIRs with better outcome in haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia
por: Zhang, Yu, et al.
Publicado: (2023)

Self-Association of an Activating Natural Killer Cell Receptor, KIR2DS1
por: Hayley, Michael, et al.
Publicado: (2011)

KIR3DL01 upregulation on gut natural killer cells in response to SIV infection of KIR- and MHC class I-defined rhesus macaques
por: Ries, Moritz, et al.
Publicado: (2017)

Interaction between human leukocyte antigen (HLA-C) and killer cell Ig-like receptors (KIR2DL) inhibits the cytotoxicity of natural killer cells in patients with hepatoblastoma
por: Guo, Jing-Jie, et al.
Publicado: (2022)

Conjunctival Scarring in Trachoma Is Associated with the HLA-C Ligand of KIR and Is Exacerbated by Heterozygosity at KIR2DL2/KIR2DL3
por: Roberts, Chrissy h., et al.
Publicado: (2014)

IFCC Professional Scientific Exchange Programme Expression of CD85, a Killer-Cell Inhibitory Receptor (KIR) Molecule on T Cells in B-Chronic Lymphocytic Leukemia (B-CLL)
por: Siftar, Zoran
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_pgfkljt1eml2f5s1vl3veclgcn